~~<i id='93A0884686'><strike id='93A0884686'><tt id='93A0884686'><pre id='93A0884686'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：comprehensive 2025-10-02 00:52:46 - browse：437

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Hospitals are dialing back on venture capital investing

hotspot

explore

hotspot

knowledge

2:58FormerPresidentandRepublicanpresidentialcandidateDonaldTrumpreactsasheholdsacampaignrallyinErie,

WSS

Be careful with at

ALS groups 'won't be played again' by the FDA, drug sponsors

Illinois Supreme Court finds assault weapons ban constitutional

Congress gives doctors Medicare pay bump

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Novo Nordisk touts Wegovy study, but still struggling with supply

focus

Wikipedia

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

BMS, looking to build heart drug business, turns to AI for diagnosis

New air purifier tech could be key to improving indoor air quality

Senators push IRS to launch nonprofit hospital probe

Virginia high school admissions case could be legal follow

Clinical trials giant ICON acquires HumanFirst

BioMarin wins approval for gene therapy to treat hemophilia A

RaDonda Vaught to speak at CommonSpirit event on patient safety

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Obesity now affects over 1 billion people worldwide, study finds

explore

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Change Healthcare cyberattack outage could last weeks

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Bird flu researchers hone in on Finland’s mink farms

Indictment alleges Trump's ex

Medical device lobby: We're tired of waiting on Medicare coverage

explore

hotspot

hotspot

knowledge